. Purpose: In recent years, there has been a migration toward the use of glycated hemoglobin (HbA1c) in determining glycemic control. This study aimed to quantify the associations between changes in body weight, sedentary time, and moderate to vigorous physical activity (MVPA) time with HbA1c levels for a 3-yr period among adults at high risk of type 2 diabetes. Methods: This study reports baseline and 3-yr follow-up data from the Walking Away from Type 2 Diabetes study. ActiGraph GT3X accelerometers captured sedentary time and MVPA. Linear regression examined the independent associations of changes in sedentary time, MVPA, and body weight with HbA1c between baseline and 3-yr follow-up. Results: The sample composed of 489 participants (mean age = 64.2 T 7.3 yr, body mass index = 31.7 T 5.1, 63.4% male) with valid baseline and follow-up accelerometer, body weight, and HbA1c data. After adjustment for known confounders, an increase in MVPA time (per 30 minId j1 ) was associated with a decrease in HbA1c percentage (A = j0.11 [j0.18 to j0.05], P = 0.001), and an increase in body weight (per 6 kg) was associated with an increase in HbA1c percentage (A = 0.08 [0.04-0.12], P G 0.001). The presence of dysglycemia at baseline (HbA1c Q 6.0%) strengthened these associations (P G 0.001 for interactions). Change in sedentary time was not significantly associated with change in HbA1c after adjustment for change in MVPA time. Conclusion: Increases in MVPA and body weight were associated with a reduction and increase in HbA1c, respectively, particularly in those with dysglycemia. Quantifying the effect that health behavior changes have on HbA1c can be used to inform prevention programs.
T ype 2 diabetes mellitus (T2DM) is one of the most prevalent chronic diseases and accounts for between 7% and 14% of health care expenditure globally (40) . Both the prevalence and the cost of T2DM in the United Kingdom are projected to rise in the future with 17% of the National Health Service (NHS) budget required for its treatment by 2035 (19) . Given this current and projected increase in burden, health care policies and recommendations targeting prevention are gaining national and international traction with defined budgetary commitments (27, 29) .
Lifestyle interventions have consistently been shown to reduce the risk of, and slow progression to, T2DM in highrisk populations and form the cornerstone of diabetes prevention recommendations and programs (10, 26) . There has been a wealth of good quality interventional and epidemiological evidence quantifying the combined and individual effect of lifestyle factors in improving glucose regulation and reducing the risk of T2DM based on outcomes from an oral glucose tolerance test (fasting and 2-h postchallenge glucose levels) (11) . However, such data no longer reflects clinical reality and decision making processes. Since the inclusion of HbA1c within the diagnostic framework for T2DM (36) , there has been a migration toward HbA1c in the classification of diabetes risk and assessment of diabetes prevention programs run within routine care (20, 26, 27) . This change is reflective of greater clinical utility of HbA1c compared with plasma glucose derived from an oral glucose tolerance test. For example, HbA1c does not need to be measured fasting, is a better indicator of chronic hyperglycemia, is less affected by any short-term illness-related changes in plasma glucose levels, and shows lower intertest variability (20) . Given the abundant shift in focus toward HbA1c in recent years, there is a requirement to extend prevention research by quantifying the effect of lifestyle change on this metabolic marker.
Increased physical activity and weight loss have consistently been shown to independently reduce the risk of T2DM and are key behavioral targets for prevention programs that have been translated into real-world settings (6, 21) . The importance of these factors on change in HbA1c needs further elucidation, although recent research is encouraging. For example, obese individuals with currently normal HbA1c levels (5.2%-5.6%) have a greater chance of developing early onset T2DM than a lighter individual with currently higher levels (5.7%-6.4%) (25) . In addition to physical activity and body weight, high levels of sedentary time, defined as any sitting or reclining behaviors undertaken with low energy expenditure, have also been associated with poor metabolic health (8) , increased risk of T2DM (4, 8, 34) , cardiovascular disease (4, 34) , and mortality (4, 34) . Recent cross-sectional links between sedentary time and insulin sensitivity have also emerged, which further support the potentially detrimental effect of sedentary time upon glycemic control (5, 39) .
The aim of this article is to use a prospective data set to quantify the association between changes in moderate to vigorous physical activity (MVPA), sedentary time, and body weight with changes in HbA1c using a population at high risk of T2DM recruited from primary care for a 3-yr period.
METHODS
Research design. This study performed an observational cohort analysis using baseline and 3-yr follow-up data from the Walking Away from Type 2 Diabetes trial, the design and results of which are described elsewhere (37, 38) . In brief, this was a randomized controlled trial that evaluated the effectiveness of a pragmatic structured education program aimed at increasing physical activity and promoting healthy lifestyles for 3 yr among those who were at high risk of T2DM.
Participants. Individuals taking part in the trial were recruited through 10 primary care practices in Leicestershire, United Kingdom, in 2010. Individuals were recruited based on having a high risk of T2DM defined using the Leicester Practice Risk Score (13) . The score calculates risk based on six variables (age, sex, ethnicity, body mass index, family history of the disease, and antihypertensive drug usage). Individuals ranked within the top 10% within their family practice were invited to take part in the study. Those with T2DM diagnosed at baseline, with established T2DM or currently taking steroids, were excluded.
Informed consent was obtained from all eligible participants, and full ethical approval from the local ethics committee was granted for the trial.
Demographic data. Information regarding medication, ethnicity, smoking status, and home postcode (used to calculate index of multiple deprivation [IMD] score) was obtained after an interview administered protocol conducted by health care professionals. The IMD scores are publically available continuous measures of compound social and material deprivation, which are calculated using a variety of data including current income, employment, health, education, and housing.
Anthropometric data. Body weight, body fat percentage (Tanita TBE 611; Tanita, West Drayton, UK), and height were measured to the nearest 0.1 kg, 0.1%, and 0.1 cm, respectively.
Biochemical data. Venous blood samples were obtained after a 12-h overnight fast. All assays were measured in the same laboratory using stable methodologies and conducted by individuals blinded to the patients" identity. Glycated hemoglobin (HbA1c) was analyzed using the Bio-Rad Variant II HPLC system (Bio-Rad Clinical Diagnostics, Hemel Hempstead, UK). All venipuncture was undertaken by trained phlebotomists. Data collection procedures between baseline and follow-up were standardized.
Accelerometer data. Participants were asked to wear an accelerometer (ActiGraph GT3X, Pensacola, FL) on the right anterior axillary line above the hip for seven consecutive days during waking hours at both baseline and 3-yr follow-up. Data were collected in 60-s epochs. Freedson cut points, using counts in the vertical axis only, were used to categorize sedentary time (G100 counts per minute) and MVPA time (Q1952 counts per minute) (9) . In addition, MVPA time accumulated in bouts Q10 min (allowing for a 2-min exception in the intensity threshold) was also derived. Non-wear time was defined as a minimum of 60 min of continuous zero counts, and days with at least 600 min of wear time were considered valid (16) . To be included in the analysis, a minimum of any four valid days was required (32) . Accelerometer files were processed using KineSoft V3.3.76, a commercially available analytical software (KineSoft, Loughborough, UK).
Statistical analysis and data inclusion. From the 808 individuals randomized into the Walking Away from Type 2 Diabetes trial at baseline, 489 (61%) had valid measures of accelerometer data, body weight, and HbA1c at both baseline and 3 yr and were subsequently included in this analysis. Of the 319 participants who were not included in this analysis, 289 were excluded on the basis of failing to meet the minimum accelerometer wear time requirements, whereas 30 did not provide biochemical data at both time points. The results of this intervention are reported elsewhere (38) with no significant changes to MVPA, sedentary time, or body weight for the overall cohort. All analyses were conducted using IBM SPSS Statistics (version 22.0), and statistical significance was set at P G 0.05. Only participants with valid measures of accelerometer data, body weight, and HbA1c at both baseline and 3 yr were included in the following analyses.
Linear regression models examined the independent associations between changes in MVPA, sedentary time, and body weight with a change in HbA1c for the 3-yr period. Changes in all variables were calculated as 3-yr follow-up data minus baseline data. Beta-coefficients representing changes in ''HbA1c %'' reflect absolute changes in HbA1c units and not relative statistical percentage changes. Change data for MVPA and sedentary time were displayed in 30-minId j1 unit increments for ease of interpretation. The lifestyle intervention arm of the Diabetes Prevention Program targeted a 7% reduction in body weight (2) ; change data for body weight in the current study were therefore displayed in 6-kg unit increments, as this represents a 7% difference in the average body weight of our cohort. Analyses were adjusted for the following variables: age, sex, ethnicity, beta-blocker use for hypertension, IMD score, change in accelerometer wear time, and baseline measures of HbA1c, body weight, sedentary time, and MVPA. Smoking status was also added as a measure of deprivation. Additional models simultaneously added change in all variables (MVPA, sedentary time, and body weight) into the same model to establish the extent to which associations with HbA1c were independent of one another. A sensitivity analysis was conducted to see whether using MVPA time accumulated from bouts lasting Q10 min (in line with public health physical activity guidelines [35] ) influenced the findings.
In addition, we also set out to investigate whether glycemic status at baseline independently modified associations by adding interaction terms to the model. Interaction significance was set to P G 0.01. Glycemic status was defined as having dysglycemia (HbA1c Q 6.0% at baseline) or normal glycemia (G6% at baseline). Significant interactions were followed up with stratified analyses. A threshold of 6.0% was chosen to make the analysis consistent with recommendation for UK populations (26) and with international guidance (20) .
Although commonly used, a cutoff value of G100 counts per minute to categorize sedentary time may be too high, particularly in older adults (1) . We therefore ran a further sensitivity analysis to address whether similar results were yielded if sedentary time was categorized at a lower cutoff value of G50 counts per minute. Similarly, Freedson cut points for MVPA (Q1952 counts per minute) may underestimate time spent in MVPA (12); therefore, we conducted a sensitivity analysis to determine whether a lower cut point (Q1041 counts per minute) influenced our findings.
RESULTS
Those included in this analysis had a similar ethnic breakdown and baseline sedentary time compared with those who were excluded. There were also no significant differences in sex between those included and excluded. However, those excluded had a higher social deprivation score (22.7 vs 17.6, P G 0.001), were more likely to be younger (61.8 T 9.1 vs 64.2 T 7.3 yr, P G 0.001), have a higher body mass index (33.
, P G 0.001). Table 1 reports the demographic, anthropometric, and cardiometabolic characteristics of those included in the study analysis. Table 2 reports baseline and 3-yr follow-up data for key anthropometric, cardiometabolic, and accelerometer derived measures. Table 3 Body weight. When adjusting for all covariates, including change in MVPA, an increase in body weight (per 6 kg) was associated with significantly greater HbA1c levels (A = 0.08% [0.04 to 0.12], P G 0.001).
Sensitivity analyses revealed that these results were largely unaffected when using MVPA accumulated in bouts Q10 min (see Table, Supplemental Digital Content 1, Sensitivity analysis showing adjusted associations when using MVPA time accumulated in bouts Q10 min, http://links.lww.com/MSS/ A852), when using lower cut points for sedentary time (see Table, Supplemental Digital Content 2, Sensitivity analysis showing adjusted associations when using lower sedentary time cut points, http://links.lww.com/MSS/A853), or when using lower MVPA cut points (see Table, Supplemental When interaction terms were added to the model, they revealed that glycemic status at baseline significantly modified the independent associations between a change in MVPA (P G 0.001) and a change in body weight (P G 0.001) with a change in HbA1c. Following up on this interaction, stratification by glycemic status showed that those with dysglycemia had stronger associations compared with those with normal glycemia (Table 4 ). For individuals with dysglycemia, each 30-min increase in MVPA per day was associated with a 0.17% (0.04-0.29) decrease in HbA1c in the fully adjusted model (including change in sedentary time and body weight, P = 0.012), and each 6-kg increase in body weight was associated with a 0.19% (0.11-0.27) increase in HbA1c (P G 0.001). Glycemic status did not significantly modify the association between sedentary time and HbA1c and, therefore, did not warrant further stratification.
DISCUSSION
Although the effect of physical activity and weight loss interventions on HbA1c has been well established in those with T2DM (3, 33) , the effect of individual lifestyle components on HbA1c in nondiabetic populations is not as well defined. This study helps to address this evidence gap by quantifying the relative importance of changes to MVPA, sedentary time, and body weight in the regulation of HbA1c levels in those at high risk of T2DM.
The current study demonstrated that both change in MVPA and body weight were independently associated with change in HbA1c, whereby every 30-min increase in MVPA per day was associated with a 0.11% (1.2 mmolImol j1 ) decrease in HbA1c and every 6-kg increase in body weight was associated with a 0.08% (0.9 mmolImol j1 ) increase. Of note, we found that there was a significant interaction with glycemic status whereby those with dysglycemia at baseline had stronger associations of MVPA and body weight with HbA1c, further supporting the importance of lifestyle change in those with nondiabetic hyperglycemia.
Using linear scaling from data published for the large Atherosclerosis Risk in Communities study (30) , it is suggested that each 0.1 absolute percentage increase in HbA1c (1.1 mmolImol
j1
) is associated with a 6.1% increased risk of diabetes, a 1.8% increased risk of coronary artery disease, a 3% increased risk of stroke, and a 1.1% increased risk of all-cause mortality in nondiabetic populations. Therefore, the change in HbA1c associated with a 30-min change in MVPA or a 6-kg change in body weight is likely to be clinically meaningful in a nondiabetic population.
Our findings are consistent with that of the Finnish Diabetes Prevention Study (FDPS), which achieved around a 0.2% reduction in HbA1c for 3 yr with an intervention aimed at achieving a 5% body weight loss, at least 30 min of MVPA per day, and a healthy diet in those with impaired glucose tolerance (22) .
However, results from the Look Ahead study, which focused on achieving similar parameters to the FDPS, observed a reduction in HbA1c of 0.36% (3.9 mmolImol j1 ) for a 4-yr period (23) . This supersedes both the results of the FDPS mentioned earlier and the associations that attaining such parameters would have in the current study. However, their use of overweight and obese diabetic participants may have steepened the gradient for improvement beyond that observed in nondiabetic populations.
Results of the current analysis are also consistent with crosssectional analyses from national surveys, which have reported associations of MVPA, but not sedentary time, with HbA1c (14, 28, 31) and extend previous research that has demonstrated the effect of physical activity and body weight with risk of T2DM based on fasting or 2-h glucose values (11) . The current study supports MVPA and body weight as key targets for the prevention of T2DM when assessed by HbA1c. However, the results for change in sedentary time were more equivocal. Although sedentary time has been associated with an increased risk of T2DM (4, 34) and metabolic syndrome (8) , the degree to which this is independent of MVPA or total physical activity levels has remained controversial (24) . This study found that although change in sedentary time was associated with change in HbA1c, the findings were attenuated when adjusted for MVPA. This finding is in contrast to studies which have found associations between sedentary time and 2-h postchallenge glucose and levels of insulin sensitivity (15, 18, 39) , in addition to experimental interventions that have found improved postprandial glucose responses with reductions to sitting time (7, 17) . This discrepancy in findings could result from the properties of HbA1c, which reflect average glucose concentration and may therefore be less sensitive to the more subtle effects on postprandial responses and peripheral insulin sensitivity.
The Walking Away from Type 2 Diabetes randomized controlled trial (37) , from which the data in this analysis were derived from, experienced no differences between control and lifestyle intervention groups, with a small decrease in activity levels for the entire cohort (38) . A wide range of variation in both directions allowed the current analysis to be undertaken but demonstrates the challenging nature of initiating and sustaining the amount of physical activity required to elicit clinically significant results.
The main strength of this study is that it provides novel prospective evidence in a high-risk primary care population using objective measures of sedentary behavior, physical activity, and body weight. Despite the prospective nature of this study, direct causality cannot be inferred, and it is possible that unmeasured lifestyle factors were confounding relationships. In addition, although the study population is likely to be broadly representative of those referred into diabetes prevention pathways within primary care, their high-risk nature means the results are not be generalizable to the general population.
In conclusion, increasing MVPA and reducing body weight both have favorable influences on HbA1c levels in those identified as being at high risk of T2DM through a primary care setting. Through the use of regression modeling, this study is able to quantify the effect that manipulating important behavioral targets would have on HbA1c levels. This addresses an important limitation and can be used to inform future diabetes prevention interventions within primary care. Given the observational nature of this study, further research is needed to confirm these results.
